AI and PET scans could replace needle biopsies for prostate cancer grading
NCT ID NCT07266129
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether combining PSMA PET scans with machine learning can accurately grade prostate cancer without invasive biopsies. Researchers will enroll 220 men with suspected or confirmed prostate cancer. If successful, this approach could reduce unnecessary biopsies and help doctors better identify aggressive tumors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitetssykehuset Nord Norge, Tromsø
RECRUITINGTromsø, Troms, 9019, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper eye on prostate cancer return: PSMA PET vs. MRI
- AI may help spot dangerous prostate cancer and spare men from needless biopsies
- Blood test may spot prostate cancer without a needle
- AI reads scans to spot prostate cancer, spare unnecessary biopsies
- Extra numbing shot may ease pain of prostate biopsy
- Community-Led push to catch prostate cancer early in black men